Cambridge, UK, 1st October 2026: CN Bio, a leading Organ-on-a-chip (OOC) company de-risking drug discovery and development pipelines by enabling
Investigate the validated core application areas that our PhysioMimix® products and services support
Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks
PhysioMimix® is a suite of hardware, consumables and assay protocols that enable you to recreate complex human biology and accurately predict human drug responses.
Cambridge, UK, 1st October 2026: CN Bio, a leading Organ-on-a-chip (OOC) company de-risking drug discovery and development pipelines by enabling